Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results
Crossref DOI link: https://doi.org/10.1186/s13058-016-0773-6
Published Online: 2016-12-13
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Perez, Edith A.
López-Vega, José Manuel
Petit, Thierry
Zamagni, Claudio
Easton, Valerie
Kamber, Julia
Restuccia, Eleonora
Andersson, Michael
Funding for this research was provided by:
F. Hoffman-La Roche Ltd